These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37296110)

  • 1. Persistent serum protein signatures define an inflammatory subcategory of long COVID.
    Talla A; Vasaikar SV; Szeto GL; Lemos MP; Czartoski JL; MacMillan H; Moodie Z; Cohen KW; Fleming LB; Thomson Z; Okada L; Becker LA; Coffey EM; De Rosa SC; Newell EW; Skene PJ; Li X; Bumol TF; Juliana McElrath M; Torgerson TR
    Nat Commun; 2023 Jun; 14(1):3417. PubMed ID: 37296110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
    Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
    Elife; 2023 Mar; 12():. PubMed ID: 36947108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
    Proal AD; VanElzakker MB; Aleman S; Bach K; Boribong BP; Buggert M; Cherry S; Chertow DS; Davies HE; Dupont CL; Deeks SG; Eimer W; Ely EW; Fasano A; Freire M; Geng LN; Griffin DE; Henrich TJ; Iwasaki A; Izquierdo-Garcia D; Locci M; Mehandru S; Painter MM; Peluso MJ; Pretorius E; Price DA; Putrino D; Scheuermann RH; Tan GS; Tanzi RE; VanBrocklin HF; Yonker LM; Wherry EJ
    Nat Immunol; 2023 Oct; 24(10):1616-1627. PubMed ID: 37667052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
    Thaweethai T; Jolley SE; Karlson EW; Levitan EB; Levy B; McComsey GA; McCorkell L; Nadkarni GN; Parthasarathy S; Singh U; Walker TA; Selvaggi CA; Shinnick DJ; Schulte CCM; Atchley-Challenner R; Alba GA; Alicic R; Altman N; Anglin K; Argueta U; Ashktorab H; Baslet G; Bassett IV; Bateman L; Bedi B; Bhattacharyya S; Bind MA; Blomkalns AL; Bonilla H; Brim H; Bush PA; Castro M; Chan J; Charney AW; Chen P; Chibnik LB; Chu HY; Clifton RG; Costantine MM; Cribbs SK; Davila Nieves SI; Deeks SG; Duven A; Emery IF; Erdmann N; Erlandson KM; Ernst KC; Farah-Abraham R; Farner CE; Feuerriegel EM; Fleurimont J; Fonseca V; Franko N; Gainer V; Gander JC; Gardner EM; Geng LN; Gibson KS; Go M; Goldman JD; Grebe H; Greenway FL; Habli M; Hafner J; Han JE; Hanson KA; Heath J; Hernandez C; Hess R; Hodder SL; Hoffman MK; Hoover SE; Huang B; Hughes BL; Jagannathan P; John J; Jordan MR; Katz SD; Kaufman ES; Kelly JD; Kelly SW; Kemp MM; Kirwan JP; Klein JD; Knox KS; Krishnan JA; Kumar A; Laiyemo AO; Lambert AA; Lanca M; Lee-Iannotti JK; Logarbo BP; Longo MT; Luciano CA; Lutrick K; Maley JH; Mallett G; Marathe JG; Marconi V; Marshall GD; Martin CF; Matusov Y; Mehari A; Mendez-Figueroa H; Mermelstein R; Metz TD; Morse R; Mosier J; Mouchati C; Mullington J; Murphy SN; Neuman RB; Nikolich JZ; Ofotokun I; Ojemakinde E; Palatnik A; Palomares K; Parimon T; Parry S; Patterson JE; Patterson TF; Patzer RE; Peluso MJ; Pemu P; Pettker CM; Plunkett BA; Pogreba-Brown K; Poppas A; Quigley JG; Reddy U; Reece R; Reeder H; Reeves WB; Reiman EM; Rischard F; Rosand J; Rouse DJ; Ruff A; Saade G; Sandoval GJ; Santana JL; Schlater SM; Sciurba FC; Shepherd F; Sherif ZA; Simhan H; Singer NG; Skupski DW; Sowles A; Sparks JA; Sukhera FI; Taylor BS; Teunis L; Thomas RJ; Thorp JM; Thuluvath P; Ticotsky A; Tita AT; Tuttle KR; Urdaneta AE; Valdivieso D; VanWagoner TM; Vasey A; Verduzco-Gutierrez M; Wallace ZS; Ward HD; Warren DE; Weiner SJ; Welch S; Whiteheart SW; Wiley Z; Wisnivesky JP; Yee LM; Zisis S; Horwitz LI; Foulkes AS;
    JAMA; 2023 Jun; 329(22):1934-1946. PubMed ID: 37278994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID.
    Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ
    J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19.
    Craddock V; Mahajan A; Spikes L; Krishnamachary B; Ram AK; Kumar A; Chen L; Chalise P; Dhillon NK
    J Med Virol; 2023 Feb; 95(2):e28568. PubMed ID: 36756925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Peluso MJ; Lu S; Tang AF; Durstenfeld MS; Ho HE; Goldberg SA; Forman CA; Munter SE; Hoh R; Tai V; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Greenhouse B; Hunt PW; Hsue PY; Martin JN; Daniel Kelly J; Glidden DV; Deeks SG; Henrich TJ
    J Infect Dis; 2021 Dec; 224(11):1839-1848. PubMed ID: 34677601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19.
    Goetzl EJ; Yao PJ; Kapogiannis D
    Am J Med; 2023 Aug; 136(8):824-829. PubMed ID: 37072092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological response to vaccination in post-acute sequelae of COVID.
    Joung S; Weber B; Wu M; Liu Y; Tang AB; Driver M; Sternbach S; Wynter T; Hoang A; Barajas D; Kao YH; Khuu B; Bravo M; Masoom H; Tran T; Sun N; Botting PG; Claggett BL; Prostko JC; Frias EC; Stewart JL; Robertson J; Kwan AC; Torossian M; Pedraza I; Sterling C; Goldzweig C; Oft J; Zabner R; Fert-Bober J; Ebinger JE; Sobhani K; Cheng S; Le CN
    BMC Infect Dis; 2023 Feb; 23(1):97. PubMed ID: 36797666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.
    Visvabharathy L; Hanson BA; Orban ZS; Lim PH; Palacio NM; Jimenez M; Clark JR; Graham EL; Liotta EM; Tachas G; Penaloza-MacMaster P; Koralnik IJ
    Front Immunol; 2023; 14():1155770. PubMed ID: 37313412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches.
    Ahamed J; Laurence J
    J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.
    Schultheiß C; Willscher E; Paschold L; Gottschick C; Klee B; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Höll JI; Gekle M; Mikolajczyk R; Binder M
    J Med Virol; 2023 Jan; 95(1):e28364. PubMed ID: 36458566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
    Mohandas S; Jagannathan P; Henrich TJ; Sherif ZA; Bime C; Quinlan E; Portman MA; Gennaro M; Rehman J;
    Elife; 2023 May; 12():. PubMed ID: 37233729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.